HR6396

The Kid PROOF Act of 2025 amends Section 7102(c) of the SUPPORT for Patients and Communities Act, specifically expanding the authorized uses of grants to prevent suicide or overdose among children, adolescents, and young adults. This bill directly broadens the scope of eligible entities that can receive these federal grants to include health care agencies, sites, facilities, nonprofit entities, and providers specializing in pediatrics and family medicine, child and adolescent mental and behavioral health specialists, children's hospitals, hospital emergency departments, and facilities operated by or in accordance with the Indian Health Service. This means a larger pool of healthcare providers can access federal funding for these specific services, creating new revenue opportunities for those specializing in youth mental health and substance abuse treatment. The money trail for this legislation involves the reallocation and expansion of existing grant funds under the SUPPORT Act. While the bill does not appropriate new funds, it directs where existing and future appropriations for this program can be spent. Healthcare providers, particularly those with established pediatric and mental health services, will be positioned to apply for and receive these grants. This includes large hospital systems with children's hospitals or specialized pediatric units, as well as mental and behavioral health service providers. The grants will support counseling for parents/guardians and the furnishing of supplies to prevent misuse of lethal means. This provides a direct financial incentive for healthcare entities to expand or enhance their youth suicide and overdose prevention programs. Historically, increased federal funding for specific healthcare initiatives has led to revenue growth for companies operating in those areas. For example, when the 21st Century Cures Act passed in December 2016, which included provisions for mental health and substance abuse funding, companies like Universal Health Services ($UHS) and HCA Healthcare ($HCA), which operate psychiatric facilities and hospitals, saw their stock prices rise by approximately 5% and 3% respectively in the subsequent month as investors anticipated increased demand and funding for their services. Similarly, diagnostic and laboratory service providers like LabCorp ($LH) and Quest Diagnostics ($DGX) could see increased demand for related screenings. Staffing agencies like AMN Healthcare Services ($AMN) may also benefit from increased demand for specialized mental health professionals. Specific winners include large hospital systems with robust pediatric and mental health divisions, such as Universal Health Services ($UHS) and HCA Healthcare ($HCA). Specialized mental health service providers and children's hospitals will also benefit. Diagnostic companies like LabCorp ($LH) and Quest Diagnostics ($DGX) could see increased testing related to substance abuse and mental health. Healthcare staffing companies such as AMN Healthcare Services ($AMN) stand to gain from increased demand for qualified professionals. The bill is currently referred to the Committee on Energy and Commerce and the Committee on Education and Workforce. The next step involves committee hearings and potential markups. Given the bipartisan sponsorship (Rep. James R-MI, Mrs. Dingell D-MI, Ms. Salazar R-FL, and Ms. Craig D-MN), it has moderate momentum, but passage is not guaranteed in this early stage. Losers are not directly identified by this bill, as it expands opportunities rather than restricting them. However, entities that do not adapt their services to meet the new grant criteria or lack the infrastructure for pediatric mental health and substance abuse treatment will miss out on these new funding streams.